Home > Pulmonology > NLC 2022 > Challenges in Upper Airway Diseases > CRSwNP outlined

CRSwNP outlined

Presented By
Dr Sanna Toppila-Salmi, University of Helsinki, Finland
Conference
NLC 2022
Doi
https://doi.org/10.55788/7c415afd
Chronic rhinosinusitis with nasal polyps (CRSwNP) and non-steroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease (NERD) occur more often than previously assumed. A lack of knowledge as well as limited nasal endoscopy facilities/access are likely explanations for the underdiagnosis of both conditions in the general population. CRS – with or without nasal polyps – is defined as the presence of two or more symptoms lasting for over 12 weeks, i.e. obstruction OR drainage +/- loss of smell, facial pain/pressure AND endoscopic polyps/mucus/oedema OR mucosal change on CT sinus scans [1]. The estimated prevalence of chronic rhinosinusitis without nasal polyps (CRSsNP) is 90/1000 individuals, for asthma: 100/1000 and for CRSwNP: >10/1000; NERD has a prevalence of <10/1000 . It needs to be noted that accurate diagnostics are often lacking [1,2]. “Therefore, the true number may be higher,” Dr Sanna Toppila-Salmi (University of Helsinki, Finla...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on